psalexa
logo

Dietary Supplements Market

Global Dietary Supplements Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: CP10191
Available Format:

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Product

1.3.2. Market Segmentation by Application

1.3.3. Market Segmentation by Geography

1.3.4. Analysis Period

1.3.5. Market Data Reporting Unit

1.3.5.1. Value

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participant

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Definition of Market Segments

4.1.1. By Product

4.1.1.1. Vitamin supplements

4.1.1.2. Mineral supplements

4.1.1.3. Botanical supplements

4.1.1.4. Fatty acid supplements

4.1.2. By Application

4.1.2.1. Food and beverages

4.1.2.2. Cattle pharmaceuticals

4.1.2.3. Personal care

4.1.3. By Region

4.1.3.1. North America

4.1.3.2. Europe

4.1.3.3. Asia-Pacific

4.1.3.4. Rest of the World

4.2. Value Chain Analysis

4.3. Market Dynamics

4.3.1. Trends

4.3.2. Drivers

4.3.2.1. Drivers

4.3.2.2. Impact analysis of drivers on market forecast

4.3.3. Restraints

4.3.3.1. Restraints

4.3.3.2. Impact analysis of restraints on market forecast

4.3.4. Opportunities

4.4. Porter’s Five Forces Analysis

Chapter 5. Global Market Size and Forecast

5.1. By Product

5.1.1. Vitamin supplements

5.1.2. Mineral supplements

5.1.3. Botanical supplements

5.1.4. Fatty acid supplements

5.2. By Application

5.2.1. Food and beverages

5.2.2. Cattle pharmaceuticals

5.2.3. Personal care

5.3. By Region

5.3.1. North America

5.3.2. Europe

5.3.3. Asia-Pacific

5.3.4. Rest of the World

Chapter 6. North America Market Size and Forecast

6.1. By Product

6.1.1. Vitamin Supplements

6.1.2. Mineral Supplements

6.1.3. Botanical Supplements

6.1.4. Fatty acid Supplements

6.2. By Application

6.2.1. Food and Beverages

6.2.2. Cattle Pharmaceuticals

6.2.3. Personal Care

6.3. By Country – U.S. and Canada

Chapter 7. Europe Market Size and Forecast

7.1. By Product

7.1.1. Vitamin Supplements

7.1.2. Mineral Supplements

7.1.3. Botanical Supplements

7.1.4. Fatty acid Supplements

7.2. By Application

7.2.1. Food and Beverages

7.2.2. Cattle Pharmaceuticals

7.2.3. Personal Care

7.3. By Country – Germany, France, U.K., and Others

Chapter 8. Asia-Pacific Market Size and Forecast

8.1. By Product

8.1.1. Vitamin Supplements

8.1.2. Mineral Supplements

8.1.3. Botanical Supplements

8.1.4. Fatty acid Supplements

8.2. By Application

8.2.1. Food and Beverages

8.2.2. Cattle Pharmaceuticals

8.2.3. Personal Care

8.3. By Country – China, Japan, India and Others

Chapter 9. Rest of the World Market Size and Forecast

9.1. By Product

9.1.1. Vitamin Supplements

9.1.2. Mineral Supplements

9.1.3. Botanical Supplements

9.1.4. Fatty acid Supplements

9.2. By Application

9.2.1. Food and Beverages

9.2.2. Cattle Pharmaceuticals

9.2.3. Personal Care

9.3. By Country – Brazil, Mexico, and Others

Chapter 10. Competitive Landscape

10.1. Market Share Analysis of Major Players

10.2. Competitive Analysis of Key Players

10.3. Global Strategic Developments of Key Players

Chapter 11. Company Profiles

11.1. NBTY, Inc.

11.1.1. Business Overview

11.1.2. Product and Service Offerings

11.1.3. Key Financial Summary

11.1.4. Strategic Growth Plans

11.2. Koninklijke DSM N.V

11.2.1. Business Overview

11.2.2. Product and Service Offerings

11.2.3. Key Financial Summary

11.2.4. Strategic Growth Plans

11.3. Amway

11.3.1. Business Overview

11.3.2. Product and Service Offerings

11.3.3. Key Financial Summary

11.3.4. Strategic Growth Plans

11.4. Abott Nutrition Herbalife Ltd.

11.4.1. Business Overview

11.4.2. Product and Service Offerings

11.4.3. Key Financial Summary

11.4.4. Strategic Growth Plans

11.5. Omega Protein Corporation

11.5.1. Business Overview

11.5.2. Product and Service Offerings

11.5.3. Key Financial Summary

11.5.4. Strategic Growth Plans

11.6. Bayer AG

11.6.1. Business Overview

11.6.2. Product and Service Offerings

11.6.3. Key Financial Summary

11.6.4. Strategic Growth Plans

11.7. Abott Nutrition

11.7.1. Business Overview

11.7.2. Product and Service Offerings

11.7.3. Key Financial Summary

11.7.4. Strategic Growth Plans

11.8. ReBound Health International, Inc.

11.8.1. Business Overview

11.8.2. Product and Service Offerings

11.8.3. Key Financial Summary

11.8.4. Strategic Growth Plans

11.9. NaturaLife Asia Co., Ltd.

11.9.1. Business Overview

11.9.2. Product and Service Offerings

11.9.3. Key Financial Summary

11.9.4. Strategic Growth Plans

11.10. Integrated BioPharma, Inc.

11.10.1. Business Overview

11.10.2. Product and Service Offerings

11.10.3. Key Financial Summary

11.10.4. Strategic Growth Plans

11.11. Nu Skin Enterprises, Inc.

11.11.1. Business Overview

11.11.2. Product and Service Offerings

11.11.3. Key Financial Summary

11.11.4. Strategic Growth Plans

11.12. Bio-Botanica Inc.

11.12.1. Business Overview

11.12.2. Product and Service Offerings

11.12.3. Key Financial Summary

11.12.4. Strategic Growth Plans

11.13. Surya Herbal Ltd.

11.13.1. Business Overview

11.13.2. Product and Service Offerings

11.13.3. Key Financial Summary

11.13.4. Strategic Growth Plans

11.14. Bio-Botanica Inc.

11.14.1. Business Overview

11.14.2. Product and Service Offerings

11.14.3. Key Financial Summary

11.14.4. Strategic Growth Plans

11.15. Ricola AG

11.15.1. Business Overview

11.15.2. Product and Service Offerings

11.15.3. Key Financial Summary

11.15.4. Strategic Growth Plans

11.16. Pharmavite LLC

11.16.1. Business Overview

11.16.2. Product and Service Offerings

11.16.3. Key Financial Summary

11.16.4. Strategic Growth Plans

11.17. Blackmores Ltd.

11.17.1. Business Overview

11.17.2. Product and Service Offerings

11.17.3. Key Financial Summary

11.17.4. Strategic Growth Plans

11.18. Epax AS

11.18.1. Business Overview

11.18.2. Product and Service Offerings

11.18.3. Key Financial Summary

11.18.4. Strategic Growth Plans

11.19. Axellus AS

11.19.1. Business Overview

11.19.2. Product and Service Offerings

11.19.3. Key Financial Summary

11.19.4. Strategic Growth Plans

*Note: Key financial summary and strategic growth plans will be provided on best effort basis and is subject to availability of information during primary and secondary research.

Chapter 12. Appendix

12.1. Abbreviations

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry